Highlights and Quick Summary
- Selling, General and Administrative Expense of Revenue for the quarter ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative Expense of Revenue decreased by NaN%
- Annual Selling, General and Administrative Expense of Revenue for 2021 was 3754.88% (a 89.32% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2020 was 1983.3% (a 137.17% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2019 was 836.22% (a 13.83% increase from previous year)
- Twelve month Selling, General and Administrative Expense of Revenue ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by NaN% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 0.0% | 0.0% | 2044.91% | 0.0% |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative Expense of Revenue of Atreca, Inc.
Most recent Selling, General and Administrative Expense of Revenueof BCEL including historical data for past 10 years.Interactive Chart of Selling, General and Administrative Expense of Revenue of Atreca, Inc.
Atreca, Inc. Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.0% | 0.0% | 1147.47% | – |
| 2021 | 0.0% | 5567.09% | 2301.15% | 2273.55% | 3754.88% |
| 2020 | 1813.93% | 1873.65% | 1602.48% | 3083.55% | 1983.3% |
| 2019 | 2105.17% | 0.0% | 0.0% | 0.0% | 836.22% |
| 2018 | – | – | 0.0% | 0.0% | 734.65% |
| 2017 | – | – | – | – | 265.39% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology